A mercaptoacetamide-based Class II histone deacetylase inhibitor increases dendritic spine density via RasGRF1/ERK pathway

Jung Min Song, You Me Sung, Jin Han Nam, Hyejin Yoon, Andrew Chung, Emily Moffat, Mira Jung, Daniel T.S. Pak, Jungsu Kim, Hyang Sook Hoe

Research output: Contribution to journalArticle

Abstract

Background: The accumulation of amyloid-β (Aβ) leads to the loss of dendritic spines and synapses, which is hypothesized to cause cognitive impairments in Alzheimer's disease (AD) patients. In our previous study, we demonstrated that a novel mercaptoacetamide-based class II histone deacetylase inhibitor (HDACI), known as W2, decreased Aβ levels and improved learning and memory in mice. However, the underlying mechanism of this effect is unknown. Objective: Because dendritic spine formation is associated with cognitive performance, here we investigated whether HDACI W2 regulates dendritic spine density and its molecular mechanism of action. Methods: To examine the effect of HDACI W2 on dendritic spine density, we conducted morphological analysis of dendritic spines using GFP transfection and Golgi staining. In addition, to determine the molecular mechanism of W2 effects on spines, we measured the levels of mRNAs and proteins involved in the Ras signaling pathway using quantitative real-time PCR, immunocytochemistry, and western analysis. Results: We found that HDACI W2 altered dendritic spine density and morphology in vitro and in vivo. Additionally, W2 increased the mRNA or protein levels of Ras GRF1 and phospho-ERK. Moreover, knockdown of RasGRF1 and inhibition of ERK activity prevented the W2-mediated spinogenesis in primary hippocampal neurons. Conclusion: Our Class II-selective HDACI W2 promotes the formation and growth of dendritic spines in a RasGRF1 and ERK dependent manner in primary hippocampal neurons.

Original languageEnglish (US)
Pages (from-to)591-604
Number of pages14
JournalJournal of Alzheimer's Disease
Volume51
Issue number2
DOIs
StatePublished - Mar 15 2016
Externally publishedYes

Fingerprint

Dendritic Spines
Histone Deacetylase Inhibitors
MAP Kinase Signaling System
ras-GRF1
Neurons
Messenger RNA
Amyloid
Synapses
Transfection
Real-Time Polymerase Chain Reaction
Alzheimer Disease
Proteins
Spine
Immunohistochemistry
Learning
Staining and Labeling
Growth

Keywords

  • Alzheimer's disease
  • dendritic spine
  • HDAC inhibitor
  • ras signaling

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

A mercaptoacetamide-based Class II histone deacetylase inhibitor increases dendritic spine density via RasGRF1/ERK pathway. / Song, Jung Min; Sung, You Me; Nam, Jin Han; Yoon, Hyejin; Chung, Andrew; Moffat, Emily; Jung, Mira; Pak, Daniel T.S.; Kim, Jungsu; Hoe, Hyang Sook.

In: Journal of Alzheimer's Disease, Vol. 51, No. 2, 15.03.2016, p. 591-604.

Research output: Contribution to journalArticle

Song, Jung Min ; Sung, You Me ; Nam, Jin Han ; Yoon, Hyejin ; Chung, Andrew ; Moffat, Emily ; Jung, Mira ; Pak, Daniel T.S. ; Kim, Jungsu ; Hoe, Hyang Sook. / A mercaptoacetamide-based Class II histone deacetylase inhibitor increases dendritic spine density via RasGRF1/ERK pathway. In: Journal of Alzheimer's Disease. 2016 ; Vol. 51, No. 2. pp. 591-604.
@article{0da57d74cb2c42aa82dda9258df7cc02,
title = "A mercaptoacetamide-based Class II histone deacetylase inhibitor increases dendritic spine density via RasGRF1/ERK pathway",
abstract = "Background: The accumulation of amyloid-β (Aβ) leads to the loss of dendritic spines and synapses, which is hypothesized to cause cognitive impairments in Alzheimer's disease (AD) patients. In our previous study, we demonstrated that a novel mercaptoacetamide-based class II histone deacetylase inhibitor (HDACI), known as W2, decreased Aβ levels and improved learning and memory in mice. However, the underlying mechanism of this effect is unknown. Objective: Because dendritic spine formation is associated with cognitive performance, here we investigated whether HDACI W2 regulates dendritic spine density and its molecular mechanism of action. Methods: To examine the effect of HDACI W2 on dendritic spine density, we conducted morphological analysis of dendritic spines using GFP transfection and Golgi staining. In addition, to determine the molecular mechanism of W2 effects on spines, we measured the levels of mRNAs and proteins involved in the Ras signaling pathway using quantitative real-time PCR, immunocytochemistry, and western analysis. Results: We found that HDACI W2 altered dendritic spine density and morphology in vitro and in vivo. Additionally, W2 increased the mRNA or protein levels of Ras GRF1 and phospho-ERK. Moreover, knockdown of RasGRF1 and inhibition of ERK activity prevented the W2-mediated spinogenesis in primary hippocampal neurons. Conclusion: Our Class II-selective HDACI W2 promotes the formation and growth of dendritic spines in a RasGRF1 and ERK dependent manner in primary hippocampal neurons.",
keywords = "Alzheimer's disease, dendritic spine, HDAC inhibitor, ras signaling",
author = "Song, {Jung Min} and Sung, {You Me} and Nam, {Jin Han} and Hyejin Yoon and Andrew Chung and Emily Moffat and Mira Jung and Pak, {Daniel T.S.} and Jungsu Kim and Hoe, {Hyang Sook}",
year = "2016",
month = "3",
day = "15",
doi = "10.3233/JAD-150717",
language = "English (US)",
volume = "51",
pages = "591--604",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - A mercaptoacetamide-based Class II histone deacetylase inhibitor increases dendritic spine density via RasGRF1/ERK pathway

AU - Song, Jung Min

AU - Sung, You Me

AU - Nam, Jin Han

AU - Yoon, Hyejin

AU - Chung, Andrew

AU - Moffat, Emily

AU - Jung, Mira

AU - Pak, Daniel T.S.

AU - Kim, Jungsu

AU - Hoe, Hyang Sook

PY - 2016/3/15

Y1 - 2016/3/15

N2 - Background: The accumulation of amyloid-β (Aβ) leads to the loss of dendritic spines and synapses, which is hypothesized to cause cognitive impairments in Alzheimer's disease (AD) patients. In our previous study, we demonstrated that a novel mercaptoacetamide-based class II histone deacetylase inhibitor (HDACI), known as W2, decreased Aβ levels and improved learning and memory in mice. However, the underlying mechanism of this effect is unknown. Objective: Because dendritic spine formation is associated with cognitive performance, here we investigated whether HDACI W2 regulates dendritic spine density and its molecular mechanism of action. Methods: To examine the effect of HDACI W2 on dendritic spine density, we conducted morphological analysis of dendritic spines using GFP transfection and Golgi staining. In addition, to determine the molecular mechanism of W2 effects on spines, we measured the levels of mRNAs and proteins involved in the Ras signaling pathway using quantitative real-time PCR, immunocytochemistry, and western analysis. Results: We found that HDACI W2 altered dendritic spine density and morphology in vitro and in vivo. Additionally, W2 increased the mRNA or protein levels of Ras GRF1 and phospho-ERK. Moreover, knockdown of RasGRF1 and inhibition of ERK activity prevented the W2-mediated spinogenesis in primary hippocampal neurons. Conclusion: Our Class II-selective HDACI W2 promotes the formation and growth of dendritic spines in a RasGRF1 and ERK dependent manner in primary hippocampal neurons.

AB - Background: The accumulation of amyloid-β (Aβ) leads to the loss of dendritic spines and synapses, which is hypothesized to cause cognitive impairments in Alzheimer's disease (AD) patients. In our previous study, we demonstrated that a novel mercaptoacetamide-based class II histone deacetylase inhibitor (HDACI), known as W2, decreased Aβ levels and improved learning and memory in mice. However, the underlying mechanism of this effect is unknown. Objective: Because dendritic spine formation is associated with cognitive performance, here we investigated whether HDACI W2 regulates dendritic spine density and its molecular mechanism of action. Methods: To examine the effect of HDACI W2 on dendritic spine density, we conducted morphological analysis of dendritic spines using GFP transfection and Golgi staining. In addition, to determine the molecular mechanism of W2 effects on spines, we measured the levels of mRNAs and proteins involved in the Ras signaling pathway using quantitative real-time PCR, immunocytochemistry, and western analysis. Results: We found that HDACI W2 altered dendritic spine density and morphology in vitro and in vivo. Additionally, W2 increased the mRNA or protein levels of Ras GRF1 and phospho-ERK. Moreover, knockdown of RasGRF1 and inhibition of ERK activity prevented the W2-mediated spinogenesis in primary hippocampal neurons. Conclusion: Our Class II-selective HDACI W2 promotes the formation and growth of dendritic spines in a RasGRF1 and ERK dependent manner in primary hippocampal neurons.

KW - Alzheimer's disease

KW - dendritic spine

KW - HDAC inhibitor

KW - ras signaling

UR - http://www.scopus.com/inward/record.url?scp=84961806494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961806494&partnerID=8YFLogxK

U2 - 10.3233/JAD-150717

DO - 10.3233/JAD-150717

M3 - Article

C2 - 26890742

AN - SCOPUS:84961806494

VL - 51

SP - 591

EP - 604

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -